KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Capital Expenditures (2020 - 2025)

Hims & Hers Health's Capital Expenditures history spans 6 years, with the latest figure at $189.2 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 3232.52% year-over-year to $189.2 million; the TTM value through Dec 2025 reached $226.0 million, up 1937.36%, while the annual FY2025 figure was $226.0 million, 1937.36% up from the prior year.
  • Capital Expenditures for Q4 2025 was $189.2 million at Hims & Hers Health, up from $28.9 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $189.2 million in Q4 2025 and bottomed at -$6.0 million in Q4 2024.
  • The 5-year median for Capital Expenditures is $3.1 million (2021), against an average of $12.8 million.
  • The largest annual shift saw Capital Expenditures tumbled 984.33% in 2024 before it skyrocketed 3232.52% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $933000.0 in 2021, then skyrocketed by 30.01% to $1.2 million in 2022, then plummeted by 43.69% to $683000.0 in 2023, then crashed by 984.33% to -$6.0 million in 2024, then surged by 3232.52% to $189.2 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Capital Expenditures are $189.2 million (Q4 2025), $28.9 million (Q3 2025), and $4.2 million (Q2 2025).